Agilus Diagnostics launches advanced laboratory in Bongaigaon
Agilus Diagnostics, a subsidiary of Fortis Healthcare Limited., today announced the launch of a new laboratory in Bongaigaon, Assam. The advanced laboratory has the capacity to process 25,000+ samples in a month ranging from simple routine tests to semi-specialized and…
PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome
PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announces the publication of preclinical research in Science Advances, highlighting the potential of its Tie2-activating antibody program, PMC-403, in treating Idiopathic Systemic Capillary Leak…
Bracco Announces Long-Term Strategic Partnership with ulrich medical for Syringeless Magnetic Resonance Injectors
Bracco, a global leader in diagnostic imaging, and ulrich GmbH & Co. KG, a renowned German medical device manufacturer specializing in contrast media injectors and spinal implants, announced today a new long-term partnership that will bring a Bracco-branded, state-of-the-art MR…
SK bioscience and Hilleman Laboratories Announce Joint Development of Second-Generation Zaire Ebola Virus Vaccine
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing agreement with Hilleman Laboratories, a vaccines and biologics research and development organization committed…
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States
Apotex Corp. announced today the launch of Teriparatide Injection, a single-patient-use pre-filled pen used for the treatment of osteoporosis in the United States. Teriparatide Injection is supplied as a single-patient-use pre-filled pen containing 250 mcg/mL, capable of administering 28 daily doses…
Glassbeam Awarded FedRAMP® ‘In-Process’ Status for its SaaS analytics solution for connected medical systems
Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced it has achieved the ‘In Process’ milestone as a Cloud Service Provider for listing on the FedRAMP® marketplace for their Clinsights solutions. FedRAMP is the U.S….
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
Brainomix, the AI-powered medtech solutions company, has heralded its continued US expansion with the launch of its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care. The US launch, which included its previously announced FDA cleared…
Vaccine Partner Valneva receives FDA approval for the World’s first chikungunya vaccine using Albumedix’ Recombumin®
The FDA on 10th November 2023 announced the approval of IXCHIQ®, Valneva’s vaccine against the chikungunya virus. Notably, this is the first vaccine against the mosquito-borne disease to have been granted marketing approval by the FDA. Recombumin® recombinant human albumin is included as…
WELL Health Announces Launch of WELL AI Inbox Admin: A Revolutionary AI-Powered Solution for Clinic Inbox Management
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company”), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare providers and their patients globally, is pleased to announce the launch of its…
Senhwa Biosciences Received US FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that U.S. Food and Drug Administration has approved its Phase II IND application of Silmitasertib(CX-4945) to treat patients…
